Below are the most recent publications written about "Narcotic Antagonists" by people in Profiles.
-
Tatara E, Ozik J, Pollack HA, Schneider JA, Friedman SR, Harawa NT, Boodram B, Salisbury-Afshar E, Hotton A, Ouellet L, Mackesy-Amiti ME, Collier N, Macal CM. Agent-Based Model of Combined Community- and Jail-Based Take-Home Naloxone Distribution. JAMA Netw Open. 2024 Dec 02; 7(12):e2448732.
-
Abbasloo E, Esmaeili-Mahani S, Kobeissy F, Currier Thomas T. Evidence for the Induction of Analgesic Cross-Tolerance Between Opioid and Apelin/APJ Systems in Male Rats. J Stud Alcohol Drugs. 2024 Sep; 85(5):704-712.
-
Luo SX, Feaster DJ, Liu Y, Balise RR, Hu MC, Bouzoubaa L, Odom GJ, Brandt L, Pan Y, Hser YI, VanVeldhuisen P, Castillo F, Calderon AR, Rotrosen J, Saxon AJ, Weiss RD, Wall M, Nunes EV. Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment. JAMA Psychiatry. 2024 01 01; 81(1):45-56.
-
Brandt L, Hu MC, Liu Y, Castillo F, Odom GJ, Balise RR, Feaster DJ, Nunes EV, Luo SX. Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder. Am J Psychiatry. 2023 05 01; 180(5):386-394.
-
Santiago D, Rosario Y, Melin K, Duconge J, Roman L, Gonzalez A, Venkataramanan R. Brand-to-Generic Substitution of Buprenorphine/Naloxone Sublingual Film in Puerto Rico: A Case Study. P R Health Sci J. 2021 12; 40(4):192-194.
-
Saraiya P, Hutchins SS, Crump S, Morgan J, Wilkinson T, Walker CD, Taylor B. Availability of Naloxone in 2 Underserved Urban Communities in Georgia. J Public Health Manag Pract. 2021 May-Jun 01; 27(Suppl 3):S179-S185.
-
Melin K, Santiago Qui?ones D, Rodr?guez-D?az CE. Socially distant and out of reach: Unintended consequences of COVID-19 prevention efforts on transgender and gender non-binary populations in Puerto Rico. J Subst Abuse Treat. 2021 03; 122:108209.
-
Ettienne EB, Ofoegbu A, Maneno MK, Briggs J, Ezeude G, Williams S, Walker C, Chapman E. Pharmacogenomics and Opioid Use Disorder: Clinical Decision Support in an African American Cohort. J Natl Med Assoc. 2019 Dec; 111(6):674-681.
-
Derefinko KJ, Salgado Garc?a FI, Talley KM, Bursac Z, Johnson KC, Murphy JG, McDevitt-Murphy ME, Andrasik F, Sumrok DD. Adverse childhood experiences predict opioid relapse during treatment among rural adults. Addict Behav. 2019 09; 96:171-174.
-
Lutfy K, Parikh D, Lee DL, Liu Y, Ferrini MG, Hamid A, Friedman TC. Prohormone convertase 2 (PC2) null mice have increased mu opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence. Neuroscience. 2016 08 04; 329:318-25.